NanoString Raises $30M in Private Financing | GenomeWeb

NEW YORK (GenomeWeb News) – NanoString Technologies has closed a series C financing round, raising $30 million from venture capital investors.

The Seattle-based firm said the financing was completed through two tranches, and the funds will be used to accelerate commercialization of its nCounter Analysis System for research and diagnostic applications. The system is a digital gene-expression tool that can multiplex hundreds of genes per sample.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.